Shares of US clinical-stage biotech Apogee Therapeutics closed up 20% at $79.24 yesterday, when it released positive 52-week ...

USA-based Oryon Cell Therapies, a biotech developing autologous neuron replacement medicines for Parkinson's disease and ...

Taiwan-based GlycoNex, a biotech developing glycan-directed cancer immunotherapies, has entered into a collaboration ...

US pharma giant Pfizer and French vaccine maker Valneva today announced top-line results from the Phase III VALOR "Vaccine ...

French pharma major Sanofi has entered a discovery and development agreement with privately-held California biotech Kali ...

California-based machine-learning driven drug discovery and development company, today announced the expansion of its ...

Swiss pharma giant Roche says that it has made the difficult decision not to advance emugrobart—an investigational ...

German biotech Evotec (Frankfurt: EVT) said its US subsidiary Just – Evotec Biologics have secured a multi-year contract from ...

US biotech Rhythm Pharmaceuticals (Nasdaq: RYTM) has secured US regulator approval for Imcivree (setmelanotide) in acquired ...

AI-driven biotech Earendil Labs has secured $787 million in financing to expand its biologics pipeline and internal R&D ...

Advances in genomics research and increasing adoption of high-throughput sequencing technologies are driving the demand for ...

All the news that moves the needle in pharma and biotech Exclusive features, podcasts, interviews, data analyses and ...